Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma

Cancer

Volumn 80, Issue 9, 1997, Pages 1768-1775

  Gelb, Arnold B ^a,d   Sudilovsky, Daniel ^a   Wu, C Daniel ^b   Weiss, Lawrence M ^c   Medeiros, L Jeffrey ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

DNA content; Flow cytometry; Immunohistochemistry; Intratumoral microvessel density; MIB 1; P53; Renal cell carcinoma; S phase fraction

Indexed keywords

CD31 ANTIGEN; DNA; MONOCLONAL ANTIBODY KI 67; PROTEIN P53; VON WILLEBRAND FACTOR;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER GRADING; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CONTROLLED STUDY; DIPLOIDY; DNA CONTENT; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

ADULT; AGED; ANTIGENS, NUCLEAR; CARCINOMA, RENAL CELL; CELL DIVISION; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PLOIDIES; PROGNOSIS; S PHASE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030695994     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971101)80:9<1768::AID-CNCR11>3.0.CO;2-3     Document Type: Article

References (42)

1. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297-301.
2. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 1971;28:1165-77.
3. Medeiros LJ, Gelb AB, Weiss LM. Low-grade renal cell carcinoma. A clinicopathologic study of 53 cases. Am J Surg Pathol 1987;11:633-42.
4. Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer 1988;61:1639-51.
5. Robson CJ. Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Prog Clin Biol Res 1982;100:481-8.
6. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. American Joint Committee on Cancer. Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992:201-4.
7. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: Lippincott-Raven, 1997.
8. Selli C, Hinshaw WM, Woodard BH, Paulson DF. Stratification of risk factors in renal cell carcinoma. Cancer 1983;52:899-903.
9. Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S, Morales P. Renal cell carcinoma: survival and prognostic factors. Urology 1986;27:291-301.
10. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-63.
11. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ. Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am J Surg Pathol 1993;17:275-86.
12. Bevilacqua P, Barbareschi M, Verderio P, Boracchi P, Caffo O, Dalla Palma P, et al. Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of a multiparametric study. Breast Cancer Res Treat 1995;36:205-17.
13. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995;87:1603-12.
14. Sahin AA, Ro JY, Brown RW, Ordonez NG, Cleary KR, el-Naggar AK, et al. Assessment of Ki-67-derived tumor prolif-erative activity in colorectal adenocarcinomas. Mod Pathol 1994;7:17-22.
15. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992;340:1369-73.
16. Bot FJ, Godschalk JC, Krishnadath KK, van der Kwast TH, Bosman FT. Prognostic factors in renal-cell carcinoma: immunohistochemical detection of p53 protein versus clinicopathological parameters. Int J Cancer 1994;57:634-7.
17. Ciancio G, Ferrell S, Block NL. Flow-cytometric DNA analysis of paraffin-embedded renal cell carcinoma tissue from patients treated by parenchymal-sparing surgery. Br J Urol 1995;76:570-4.
18. Flint A, Grossman HB, Liebert M, Lloyd RV, Bromberg J. DNA and PCNA content of renal cell carcinoma and prognosis. Am J Clin Pathol 1995;103:14-9.
19. Grignon DJ, Abdel-Malak M, Mertens W, Koster J, Keeney M, Sakr W, et al. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index. Mod Pathol 1995;8:18-24.
20. Lanigan D, McLean PA, Murphy DM, Donovan MG, Curran B, Leader M. Ploidy and prognosis in renal carcinoma. Br J Urol 1993;71:21-4.
21. MacLennan GT, Bostwick DG. Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 1995;46:27-30.
22. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kuhn R, Wittekind CW. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer 1996;77:164-71.
23. Yoshino S, Kato M, Okada K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int J Urol 1995;2:156-60.
24. Störkel S, Eble J, Adlakha K, Amin M, Blute M, Bostwick DG, et al. Classification of renal cell carcinoma: Workgroup No. 1. Cancer 1997;80:987-9.
25. Medeiros LJ, Jones EC, Aizawa S, Aldape H, Cheville JC, Goldstein N, et al. Grading of renal cell carcinoma: Work-group No. 2. Cancer 1997;80:990-1.
26. Gown AM, Wever N, Battifora H. Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1993;1:256-66.
27. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
28. Walsh CJ, Kay EW, Lynch T, Walsh M, Milburn C, McLean PA, et al. Evaluation of p53 protein expression in renal cell carcinoma: comparison of two antibodies. Br J Biomed Sci 1996;53:179-81.
29. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985;6:327-33.
30. Grignon DJ, el-Naggar A, Green LK, Ayala AG, Ro JY, Swanson DA, et al. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer 1989;63:1161-5.
31. Licht M, Novick A, Goormastic M. Nephron sparing surgery in incidental vs. suspected renal cell carcinoma. J Urol 1994;152:39-43.
32. de Riese WT, Crabtree WN, Allhoff EP, Werner M, Liedke S, Lenis G, et al. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma. J Clin Oncol 1993;11:1804-8.
33. Hofmockel G, Tsatalpas P, Muller H, Dammrich J, Poot M, Maurer-Schultze B, et al. Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer 1995;76:296-306.
34. Jochum W, Schroder S, al-Taha R, August C, Gross AJ, Berger J, et al. Prognostic significance of nuclear DNA content and proliferative activity in renal cell carcinomas. A clinicopathologic study of 58 patients using mitotic count, MIB-1 staining, and DNA cytophotometry. Cancer 1996;77:514-21.
35. Eskelinen M, Lipponen P, Nordling S. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma. Anticancer Res 1995;15:2279-83.
36. Shankey TV. Urological cancers. In: Bauer KD, Duque RE, Shankey TV, editors. Clinical flow cytometry: principles and application. Baltimore: Williams & Wilkins, 1993:271-301.
37. Rainwater LM, Hosaka Y, Farrow GM, Lieber MM. Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry. J Urol 1987;137:15-20.
38. Ljungberg B, Larsson P, Stenling R, Roos G. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma. J Urol 1991;146:697-9.
39. Nakano E, Kondoh M, Okatani K, Seguchi T, Sugao H. Flow cytometric analysis of nuclear DNA content of renal cell carcinoma correlated with histologic and clinical features. Cancer 1993;72:1319-23.
40. Imai Y, Strohmeyer TG, Fleischhacker M, Slamon DJ, Koeffler HP. p53 mutations and Mdm-2 amplification in renal cell cancers. Mod Pathol 1994;7:766-70.
41. Chemeris G, Loktinov A, Rempel A, Schwarz M, Bannasch P. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Virchows Arch 1995;426:563-9.
42. Gelb AB. Renal cell carcinoma: current prognostic factors. Cancer 1997;80:981-6.